Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · IEX Real-Time Price · USD
129.86
+5.41 (4.35%)
At close: May 31, 2024, 4:00 PM
130.25
+0.39 (0.30%)
After-hours: May 31, 2024, 7:53 PM EDT
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of $12.27 billion as of May 31, 2024. Its market cap has increased by 0.32% in one year.
Market Cap
12.27B
Enterprise Value
12.26B
1-Year Change
0.32%
Ranking
Category
Stock Price
$129.86
Market Cap Chart
Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $12.27B, an increase of 20,918.60%. That is a compound annual growth rate of 23.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 12.27B | 4.35% |
May 30, 2024 | 11.76B | 7.05% |
May 29, 2024 | 10.99B | 2.58% |
May 28, 2024 | 10.71B | -8.20% |
May 24, 2024 | 11.67B | -2.89% |
May 23, 2024 | 12.02B | -0.91% |
May 22, 2024 | 12.13B | -0.63% |
May 21, 2024 | 12.20B | -1.31% |
May 20, 2024 | 12.37B | -0.42% |
May 17, 2024 | 12.42B | -1.02% |
May 16, 2024 | 12.55B | 0.18% |
May 15, 2024 | 12.52B | -0.12% |
May 14, 2024 | 12.54B | 0.73% |
May 13, 2024 | 12.45B | -0.09% |
May 10, 2024 | 12.46B | -0.36% |
May 9, 2024 | 12.51B | -0.21% |
May 8, 2024 | 12.53B | -2.54% |
May 7, 2024 | 12.86B | 0.74% |
May 6, 2024 | 12.76B | 1.03% |
May 3, 2024 | 12.63B | 2.32% |
May 2, 2024 | 12.35B | -0.21% |
May 1, 2024 | 12.37B | 4.08% |
Apr 30, 2024 | 11.89B | -1.66% |
Apr 29, 2024 | 12.09B | 0.02% |
Apr 26, 2024 | 12.09B | 1.08% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Viatris | 12.62B |
ShockWave Medical | 12.57B |
Fresenius Medical Care AG & Co. KGaA | 12.48B |
Insulet | 12.41B |
Royalty Pharma | 12.36B |
United Therapeutics | 12.21B |
Bio-Techne | 12.16B |
Medpace Holdings | 11.97B |